BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32496535)

  • 21. Coordinated Actions of Cas9 HNH and RuvC Nuclease Domains Are Regulated by the Bridge Helix and the Target DNA Sequence.
    Babu K; Kathiresan V; Kumari P; Newsom S; Parameshwaran HP; Chen X; Liu J; Qin PZ; Rajan R
    Biochemistry; 2021 Dec; 60(49):3783-3800. PubMed ID: 34757726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single molecule methods for studying CRISPR Cas9-induced DNA unwinding.
    Okafor IC; Choi J; Ha T
    Methods; 2022 Aug; 204():319-326. PubMed ID: 34767923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single molecule analysis of effects of non-canonical guide RNAs and specificity-enhancing mutations on Cas9-induced DNA unwinding.
    Okafor IC; Singh D; Wang Y; Jung M; Wang H; Mallon J; Bailey S; Lee JK; Ha T
    Nucleic Acids Res; 2019 Dec; 47(22):11880-11888. PubMed ID: 31713616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The bridge helix of Cas12a imparts selectivity in cis-DNA cleavage and regulates trans-DNA cleavage.
    Parameshwaran HP; Babu K; Tran C; Guan K; Allen A; Kathiresan V; Qin PZ; Rajan R
    FEBS Lett; 2021 Apr; 595(7):892-912. PubMed ID: 33523494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
    Basila M; Kelley ML; Smith AVB
    PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-Molecule Insight Into Target Recognition by CRISPR-Cas Complexes.
    Rutkauskas M; Krivoy A; Szczelkun MD; Rouillon C; Seidel R
    Methods Enzymol; 2017; 582():239-273. PubMed ID: 28062037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational guide RNA engineering for small-molecule control of CRISPR/Cas9 and gene editing.
    Liu X; Xiong W; Qi Q; Zhang Y; Ji H; Cui S; An J; Sun X; Yin H; Tian T; Zhou X
    Nucleic Acids Res; 2022 May; 50(8):4769-4783. PubMed ID: 35446403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. gRNA validation for wheat genome editing with the CRISPR-Cas9 system.
    Arndell T; Sharma N; Langridge P; Baumann U; Watson-Haigh NS; Whitford R
    BMC Biotechnol; 2019 Oct; 19(1):71. PubMed ID: 31684940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. gRNA-transient expression system for simplified gRNA delivery in CRISPR/Cas9 genome editing.
    Easmin F; Hassan N; Sasano Y; Ekino K; Taguchi H; Harashima S
    J Biosci Bioeng; 2019 Sep; 128(3):373-378. PubMed ID: 31010727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome Editing in Chlamydomonas reinhardtii Using Cas9-gRNA Ribonucleoprotein Complex: A Step-by-Step Guide.
    Dhokane D; Kancharla N; Savarimuthu A; Bhadra B; Bandyopadhyay A; Dasgupta S
    Methods Mol Biol; 2023; 2653():207-217. PubMed ID: 36995629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical Modification of Guide RNAs for Improved CRISPR Activity in CD34+ Human Hematopoietic Stem and Progenitor Cells.
    Shapiro J; Tovin A; Iancu O; Allen D; Hendel A
    Methods Mol Biol; 2021; 2162():37-48. PubMed ID: 32926376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple approach to mediate genome editing in the filamentous fungus Trichoderma reesei by CRISPR/Cas9-coupled in vivo gRNA transcription.
    Wu C; Chen Y; Qiu Y; Niu X; Zhu N; Chen J; Yao H; Wang W; Ma Y
    Biotechnol Lett; 2020 Jul; 42(7):1203-1210. PubMed ID: 32300998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cells.
    Xu H; Kita Y; Bang U; Gee P; Hotta A
    STAR Protoc; 2021 Dec; 2(4):100965. PubMed ID: 34825222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probing the stability of the SpCas9-DNA complex after cleavage.
    Aldag P; Welzel F; Jakob L; Schmidbauer A; Rutkauskas M; Fettes F; Grohmann D; Seidel R
    Nucleic Acids Res; 2021 Dec; 49(21):12411-12421. PubMed ID: 34792162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetically modified guide RNA and donor DNA are a versatile platform for CRISPR-Cas9 engineering.
    Lee K; Mackley VA; Rao A; Chong AT; Dewitt MA; Corn JE; Murthy N
    Elife; 2017 May; 6():. PubMed ID: 28462777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and Analysis of Small Molecule Inhibitors of CRISPR-Cas9 in Human Cells.
    Yang Y; Li D; Wan F; Chen B; Wu G; Li F; Ren Y; Liang P; Wan J; Songyang Z
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Planta Processing of the SpCas9-gRNA Complex.
    Mikami M; Toki S; Endo M
    Plant Cell Physiol; 2017 Nov; 58(11):1857-1867. PubMed ID: 29040704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The length of guide RNA and target DNA heteroduplex effects on CRISPR/Cas9 mediated genome editing efficiency in porcine cells.
    Lv J; Wu S; Wei R; Li Y; Jin J; Mu Y; Zhang Y; Kong Q; Weng X; Liu Z
    J Vet Sci; 2019 May; 20(3):e23. PubMed ID: 31161741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome editing with CRISPR/Cas9 in Pinus radiata (D. Don).
    Poovaiah C; Phillips L; Geddes B; Reeves C; Sorieul M; Thorlby G
    BMC Plant Biol; 2021 Aug; 21(1):363. PubMed ID: 34376154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.